MorganRosel Wealth Management’s Boston Scientific BSX Stock Holding History

MorganRosel Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,064	Closed	-$202K	–	114
2025 Q3	$202K	Hold	2,064	–	–	0.05%	107
2025 Q2	$222K	Hold	2,064	–	–	0.06%	105
2025 Q1	$208K	Buy	+2,064	New	+$208K	0.06%	100
2024 Q4	–	Sell	-5,064	Closed	-$424K	–	104
2024 Q3	$424K	Hold	5,064	–	–	0.14%	82
2024 Q2	$390K	Hold	5,064	–	–	0.14%	83
2024 Q1	$347K	Hold	5,064	–	–	0.12%	87
2023 Q4	$293K	Hold	5,064	–	–	0.11%	85
2023 Q3	$267K	Hold	5,064	–	–	0.11%	86
2023 Q2	$274K	Hold	5,064	–	–	0.11%	84
2023 Q1	$253K	Hold	5,064	–	–	0.11%	85
2022 Q4	$234K	Buy	+5,064	New	+$219K	0.11%	88
2022 Q2	–	Sell	-5,064	Closed	-$224K	–	87
2022 Q1	$224K	Hold	5,064	–	–	0.11%	84
2021 Q4	$215K	Hold	5,064	–	–	0.1%	81
2021 Q3	$220K	Hold	5,064	–	–	0.12%	80
2021 Q2	$217K	Buy	+5,064	New	+$213K	0.12%	78

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MorganRosel Wealth Management's BSX Position: Q4 2025 in Review

MorganRosel Wealth Management sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,064 shares — an estimated $202K sold.

MorganRosel Wealth Management first reported a position in BSX in Q2 2021 and held it in 15 quarters. The position peaked at $424K in Q3 2024. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

MorganRosel Wealth Management reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
MorganRosel Wealth Management sold 2,064 Boston Scientific shares in Q4 2025, an estimated $202K.
MorganRosel Wealth Management first reported a position in Boston Scientific in Q2 2021 and held it in 15 quarters.
MorganRosel Wealth Management's Boston Scientific position peaked at $424K in Q3 2024.
1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on MorganRosel Wealth Management's 13F filing for Q4 2025, filed 13 Feb 2026.